Mounjaro 12.5 mg Tirzepatide KwikPen (0.6 ml)

Product Description

Mounjaro® KwikPen 12.5 mg (Tirzepatide) is a once-weekly, pre-filled injection pen designed to help adults with type 2 diabetes achieve better blood sugar control. Manufactured by Eli Lilly, this easy-to-use pen delivers a precise dose of tirzepatide through subcutaneous injection, offering a convenient option for patients looking for reliable glucose management.

Mounjaro works by activating GIP and GLP-1 receptors, helping the body improve insulin response, reduce appetite, and support healthy metabolic function. The 12.5 mg dose is typically used as part of a gradual dose-titration plan recommended by healthcare professionals.

Key Features

• 12.5 mg Tirzepatide per injection
• KwikPen pre-filled pen for easy, ready-to-use dosing
• Once-weekly subcutaneous administration
• Helps improve blood sugar control in adults with type 2 diabetes
• Manufactured by Eli Lilly, a trusted global pharmaceutical company
• Designed for smooth, accurate injections

Benefits of Mounjaro KwikPen

• Convenient weekly dosing
• No mixing or preparation required
• Simple pen design ideal for at-home use
• Supports metabolic health and glucose regulation

Storage Guidelines

Store refrigerated before first use. Follow packaging instructions for storage after opening.